180 related articles for article (PubMed ID: 12824050)
41. Developmental and post-injury cortical gliogenesis: a genetic fate-mapping study with Nestin-CreER mice.
Burns KA; Murphy B; Danzer SC; Kuan CY
Glia; 2009 Aug; 57(10):1115-29. PubMed ID: 19115384
[TBL] [Abstract][Full Text] [Related]
42. cDNA cloning of a mouse pituitary adenylate cyclase-activating polypeptide receptor.
Hashimoto H; Yamamoto K; Hagigara N; Ogawa N; Nishino A; Aino H; Nogi H; Imanishi K; Matsuda T; Baba A
Biochim Biophys Acta; 1996 Jun; 1281(2):129-33. PubMed ID: 8664310
[TBL] [Abstract][Full Text] [Related]
43. Altered emotional behavior in PACAP-type-I-receptor-deficient mice.
Otto C; Martin M; Wolfer DP; Lipp HP; Maldonado R; Schütz G
Brain Res Mol Brain Res; 2001 Aug; 92(1-2):78-84. PubMed ID: 11483244
[TBL] [Abstract][Full Text] [Related]
44. A transgenic mouse model for the detailed morphological study of astrocytes.
Suzuki R; Watanabe J; Arata S; Funahashi H; Kikuyama S; Shioda S
Neurosci Res; 2003 Dec; 47(4):451-4. PubMed ID: 14630350
[TBL] [Abstract][Full Text] [Related]
45. Expression and coupling of PACAP/VIP receptors in cortical neurons and type I astrocytes.
Grimaldi M; Cavallaro S
Ann N Y Acad Sci; 2000; 921():312-6. PubMed ID: 11193842
[No Abstract] [Full Text] [Related]
46. PACAP/PAC1 autocrine system promotes proliferation and astrogenesis in neural progenitor cells.
Nishimoto M; Furuta A; Aoki S; Kudo Y; Miyakawa H; Wada K
Glia; 2007 Feb; 55(3):317-27. PubMed ID: 17115416
[TBL] [Abstract][Full Text] [Related]
47. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
[TBL] [Abstract][Full Text] [Related]
48. [Physiological significance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the nervous system].
Hashimoto H
Yakugaku Zasshi; 2002 Dec; 122(12):1109-21. PubMed ID: 12510388
[TBL] [Abstract][Full Text] [Related]
49. A constitutively active pituitary adenylate cyclase activating polypeptide (PACAP) type I receptor shows enhanced photoaffinity labeling of its highly glycosylated form.
Cao Y; Gimpl G
Biochim Biophys Acta; 2001 Jul; 1548(1):139-51. PubMed ID: 11451447
[TBL] [Abstract][Full Text] [Related]
50. Pituitary adenylyl cyclase-activating polypeptide (PACAP) and its receptor (PAC1-R) are positioned to modulate afferent signaling in the cochlea.
Drescher MJ; Drescher DG; Khan KM; Hatfield JS; Ramakrishnan NA; Abu-Hamdan MD; Lemonnier LA
Neuroscience; 2006 Sep; 142(1):139-64. PubMed ID: 16876955
[TBL] [Abstract][Full Text] [Related]
51. Pituitary adenylate cyclase-activating polypeptide receptors during development: expression in the rat embryo at primitive streak stage.
Zhou CJ; Shioda S; Shibanuma M; Nakajo S; Funahashi H; Nakai Y; Arimura A; Kikuyama S
Neuroscience; 1999; 93(1):375-91. PubMed ID: 10430501
[TBL] [Abstract][Full Text] [Related]
52. Heterogeneity of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide receptors in rat intrinsic cardiac neurons.
DeHaven WI; Cuevas J
Neurosci Lett; 2002 Aug; 328(1):45-9. PubMed ID: 12123856
[TBL] [Abstract][Full Text] [Related]
53. Effects of pituitary adenylate cyclase-activating polypeptide on facial nerve recovery in the Guinea pig.
Kimura H; Kawatani M; Ito E; Ishikawa K
Laryngoscope; 2003 Jun; 113(6):1000-6. PubMed ID: 12782812
[TBL] [Abstract][Full Text] [Related]
54. Involvement of endogenous antioxidant systems in the protective activity of pituitary adenylate cyclase-activating polypeptide against hydrogen peroxide-induced oxidative damages in cultured rat astrocytes.
Douiri S; Bahdoudi S; Hamdi Y; Cubì R; Basille M; Fournier A; Vaudry H; Tonon MC; Amri M; Vaudry D; Masmoudi-Kouki O
J Neurochem; 2016 Jun; 137(6):913-30. PubMed ID: 26991551
[TBL] [Abstract][Full Text] [Related]
55. Expression of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type I A receptor mRNAs in granulosa cells of preovulatory follicles of the rat ovary.
Koh PO; Kwak SD; Kang SS; Cho GJ; Chun SY; Kwon HB; Choi WS
Mol Reprod Dev; 2000 Apr; 55(4):379-86. PubMed ID: 10694744
[TBL] [Abstract][Full Text] [Related]
56. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells.
Inagaki N; Yoshida H; Mizuta M; Mizuno N; Fujii Y; Gonoi T; Miyazaki J; Seino S
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2679-83. PubMed ID: 8146174
[TBL] [Abstract][Full Text] [Related]
57. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions.
Vaudry D; Gonzalez BJ; Basille M; Yon L; Fournier A; Vaudry H
Pharmacol Rev; 2000 Jun; 52(2):269-324. PubMed ID: 10835102
[TBL] [Abstract][Full Text] [Related]
58. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide inhibit dendritic growth in cultured sympathetic neurons.
Drahushuk K; Connell TD; Higgins D
J Neurosci; 2002 Aug; 22(15):6560-9. PubMed ID: 12151535
[TBL] [Abstract][Full Text] [Related]
59. Tissue-specific and developmental expression of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in rat brain.
D'Agata V; Cavallaro S; Stivala F; Canonico PL
Eur J Neurosci; 1996 Feb; 8(2):310-8. PubMed ID: 8714702
[TBL] [Abstract][Full Text] [Related]
60. Pituitary adenylate cyclase activating peptide (PACAP) in the enteropancreatic innervation.
Kirchgessner AL; Liu MT
Anat Rec; 2001 Jan; 262(1):91-100. PubMed ID: 11146432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
